Natalizumab for induction of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 188 Mendeley

Summary X Wikipedia Dimensions citations

So far, Dimensions has found 44 publications that cite this research output.

44

The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.

Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn’s Disease Initiating Biologics With 3 Years of Follow-Up

Article in Journal of Health Economics and Outcomes Research (November 2023)

Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn’s Disease Initiating Biologics With 3 Years of Follow-Up

Article in Journal of Health Economics and Outcomes Research (November 2023)

scDrugPrio: A framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases

Preprint in bioRxiv (November 2023)